With so many different proteins and proteoforms existing in the human proteome, understanding which proteins are involved in a given biological function or process can be incredibly challenging. One area that has been understudied is metabolism in the brain and how antiretroviral drugs such as efavirenz for human immunodeficiency virus (HIV) are metabolized locally.
In this webinar, we look closely at a new approach utilizing accurate mass targeted mass spectrometry-based proteomics to identify low abundance proteins in the brain.
We cover:
Complete the form to watch now!
Abigail Wheeler is a Senior Scientist in the Pharmacokinetics, Dynamics, Metabolism, and Bioanalysis group at Merck. She completed her graduate studies in the lab of Namandje Bumpus at the Johns Hopkins School of Medicine where she studied drug metabolism in the brain, which is the work that will be presented.